Jeffrey A Feinstein
Overview
Explore the profile of Jeffrey A Feinstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
2801
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pham J, Kong F, James D, Feinstein J, Marsden A
Cardiovasc Eng Technol
. 2024 Oct;
15(6):760-774.
PMID: 39354259
Purpose: Angioplasty with stent placement is a widely used treatment strategy for patients with stenotic blood vessels. However, it is often challenging to predict the outcomes of this procedure for...
2.
Lee J, Richter J, Pfaller M, Szafron J, Menon K, Zanoni A, et al.
Int J Numer Method Biomed Eng
. 2024 Mar;
40(5):e3820.
PMID: 38544354
The substantial computational cost of high-fidelity models in numerical hemodynamics has, so far, relegated their use mainly to offline treatment planning. New breakthroughs in data-driven architectures and optimization techniques for...
3.
Kochanski J, Feinstein J, Ogawa M, Ritter V, Hopper R, Adamson G
Pulm Circ
. 2024 Feb;
14(1):e12328.
PMID: 38348195
Children with severe Group 1 pulmonary arterial hypertension (PAH) have an unpredictable response to subcutaneous treprostinil (TRE) therapy, which may be influenced by age, disease severity, or other unknown variables...
4.
Hansen B, Vandriel S, Vig P, Garner W, Mogul D, Loomes K, et al.
Hepatology
. 2023 Dec;
79(6):1279-1292.
PMID: 38146932
Background And Aims: Alagille syndrome (ALGS) is characterized by chronic cholestasis with associated pruritus and extrahepatic anomalies. Maralixibat, an ileal bile acid transporter inhibitor, is an approved pharmacologic therapy for...
5.
Szafron J, Yang W, Feinstein J, Rabinovitch M, Marsden A
Biomech Model Mechanobiol
. 2023 Sep;
22(6):1935-1951.
PMID: 37658985
Hemodynamic loading is known to contribute to the development and progression of pulmonary arterial hypertension (PAH). This loading drives changes in mechanobiological stimuli that affect cellular phenotypes and lead to...
6.
Schramm J, Dykes J, Hopper R, Feinstein J, Rosenthal D, Kameny R
ASAIO J
. 2023 Aug;
69(11):1025-1030.
PMID: 37556563
Pediatric precapillary pulmonary hypertension can develop in response to systemic atrial hypertension. Systemic atrial decompression following ventricular assist device (VAD) implantation may not sufficiently lower pulmonary vascular resistance (PVR) to...
7.
Adamson G, Yu J, Ramamoorthy C, Peng L, Taylor A, Lennig M, et al.
Pediatr Crit Care Med
. 2023 Jul;
24(11):952-960.
PMID: 37462430
Objective: To describe the acute hemodynamic effect of vasopressin on the Fontan circulation, including systemic and pulmonary pressures and resistances, left atrial pressure, and cardiac index. Design: Prospective, open-label, nonrandomized...
8.
Szafron J, Yang W, Feinstein J, Rabinovitch M, Marsden A
bioRxiv
. 2023 May;
PMID: 37131683
Hemodynamic loading is known to contribute to the development and progression of pulmonary arterial hypertension (PAH). This loading drives changes in mechanobiological stimuli that affect cellular phenotypes and lead to...
9.
Wise-Faberowski L, Long J, Ma M, Nadel H, Shek J, Feinstein J, et al.
World J Pediatr Congenit Heart Surg
. 2023 Mar;
14(3):261-272.
PMID: 36972512
Background: In patients with tetralogy of Fallot and major aortopulmonary collaterals (MAPCAs), pulmonary blood supply is highly variable. Our approach to this condition emphasizes complete unifocalization of the pulmonary circulation,...
10.
Hopper R, van der Have O, Hollander S, Dipchand A, Perez de Sa V, Feinstein J, et al.
Pediatr Transplant
. 2023 Jan;
27(2):e14461.
PMID: 36593638
Background: Elevated pulmonary vascular resistance (PVR) in the setting of left heart failure may contribute to poor outcomes after pediatric heart transplant (HTx), but peri-transplant management is variable. Methods: We...